Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Quantum Biopharma ( (TSE:QNTM) ) just unveiled an update.
On September 18, 2025, Quantum BioPharma announced that Health Canada has granted a Product License for its natural health product, Qlarity, which enhances energy, metabolism, mental alertness, and cognitive performance. This approval allows Quantum to sell Qlarity in Canada, marking a significant milestone in its mission to bring innovative products to market. The license is expected to positively impact Quantum’s operations by expanding its market reach and enhancing its industry positioning.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative assets and biotech solutions for treating neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company is engaged in research and development through its subsidiary, Lucid Psycheceuticals Inc., and holds a strategic investment portfolio through FSD Strategic Investments Inc.
Average Trading Volume: 4,971
Technical Sentiment Signal: Hold
Current Market Cap: C$94.44M
See more insights into QNTM stock on TipRanks’ Stock Analysis page.